Spiro George Rombotis, President and CEO at Cyclacel Pharmaceuticals, Inc. (CYCC), bought 6,070 shares at $3.32 ($20K) on 2023-12-21, disclosed to the SEC on 2023-12-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CYCC | BUY | 2011-12-27 | $8K | — | Filing → |
| CYCC | BUY | 2011-09-26 | $15K | — | Filing → |
| CYCC | BUY | 2011-09-14 | $8K | — | Filing → |